AT
NEO icon

Arlington Trust’s NeoGenomics NEO Stock Holding History

Arlington Trust’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58K Hold
108
– – ﹤0.01% 704
2026
Q1 		$801 Hold
108
– – ﹤0.01% 736
2025
Q4 		$1.27K Hold
108
– – ﹤0.01% 419
2025
Q3 		$834 Hold
108
– – ﹤0.01% 575
2025
Q2 		$789 Hold
108
– – ﹤0.01% 607
2025
Q1 		$1.02K Hold
108
– – ﹤0.01% 602
2024
Q4 		$1.78K Hold
108
– – ﹤0.01% 533
2024
Q3 		$1.59K Hold
108
– – ﹤0.01% 533
2024
Q2 		$1.5K Hold
108
– – ﹤0.01% 515
2024
Q1 		$1.7K Hold
108
– – ﹤0.01% 462
2023
Q4 		$1.75K Buy
+108
New +$1.77K ﹤0.01% 655

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Arlington Trust's NEO Position: Q2 2026 in Review

Arlington Trust held its NeoGenomics (NEO) position steady in Q2 2026 at 108 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Arlington Trust first reported a position in NEO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.78K in Q4 2024. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Arlington Trust held 108 shares of NeoGenomics worth $1.58K as of Q2 2026.
  • Arlington Trust left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #704 holding.
  • Arlington Trust first reported a position in NeoGenomics in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's NeoGenomics position peaked at $1.78K in Q4 2024.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.